Today: 7 February 2026
Subscribe
Browse Category

Stock Analysis News 31 October 2025 - 4 November 2025

AT&T Stock 2025: 5G Ambitions, Big Dividend – Telecom Titan or Trap?

AT&T Stock 2025: 5G Ambitions, Big Dividend – Telecom Titan or Trap?

Company & Stock Overview AT&T Inc. is a telecom giant with a 140+ year legacy, now focused squarely on connectivity services. Its business model centers on providing voice and data communication to consumers and businesses via an expansive wireless network and a growing fiber-optic footprint. In the U.S. telecom market, AT&T operates alongside Verizon and T-Mobile in what analysts call a “durable triopoly”gurufocus.com – all three dominate market share, though each pursues a distinct strategy. AT&T’s aim is to be “America’s premier converged connectivity provider,” leveraging both high-speed 5G wireless and fiber broadband networksgurufocus.com. This dual network strategy is a
4 November 2025
····
Zoetis 2025: Animal Health Giant’s Latest Breakthroughs, Stock Outlook & Key Investor Insights

Zoetis 2025: Animal Health Giant’s Latest Breakthroughs, Stock Outlook & Key Investor Insights

Company Overview & 2025 Developments Zoetis is the global frontrunner in animal health, offering a diverse portfolio for both companion animals (pets) and farm animals. The company’s products range from vaccines and parasiticides to dermatology treatments and high-tech diagnostics. This breadth has helped Zoetis capture the #1 industry position – in 2023 its $8.5B in sales exceeded the next-largest competitor by over 50%proclinical.comproclinical.com. Zoetis continues to leverage this scale and innovation engine in 2025, focusing on pet care growth while managing challenges in livestock. Recent 2025 highlights: The first half of 2025 saw Zoetis deliver solid growth. In Q1, revenue
4 November 2025
····
Iovance Biotherapeutics (IOVA): TIL Cancer Breakthrough or Biotech Bust?

Iovance Biotherapeutics (IOVA): TIL Cancer Breakthrough or Biotech Bust?

Company Overview: Pioneering TIL Therapy in Oncology Iovance Biotherapeutics is focused on developing tumor-infiltrating lymphocyte (TIL) therapies – a novel form of immunotherapy where a patient’s own T cells, harvested from their tumor, are expanded and activated in a lab, then reinfused to attack cancer. This approach, originally pioneered by NCI’s Dr. Steven Rosenberg in the 1980s, finally reached fruition when Iovance’s lifileucel (brand name Amtagvi) earned FDA approval in 2024 as the first-ever TIL therapy (and the first cellular therapy for any solid tumor)cancer.gov. Lifileucel is indicated for unresectable or metastatic melanoma that has progressed after standard immunotherapies (e.g.
3 November 2025
···
Acrivon Therapeutics (ACRV): Precision Oncology Game-Changer or Overhyped Biotech Bet?

Acrivon Therapeutics (ACRV): Precision Oncology Game-Changer or Overhyped Biotech Bet?

Company Overview and Background Acrivon Therapeutics is a Boston-area biotech (NASDAQ: ACRV) founded in 2018, emerging with a mission to revolutionize cancer treatment through precision medicinestockanalysis.com. The company’s name “Acrivon” is derived from “accurate” or “precision,” reflecting its core approach: develop targeted oncology drugs hand-in-hand with diagnostics that pinpoint the patients who will respond. Acrivon’s proprietary platform, AP3 (Acrivon Predictive Precision Proteomics), lies at the heart of this strategy. Using proteomics and AI tools, AP3 measures the activity of myriad proteins and signaling pathways inside tumor cells in their native state, rather than just analyzing DNA mutationsglobenewswire.comglobenewswire.com. This allows Acrivon
3 November 2025
···
IDEXX Laboratories (IDXX): Inside the Pet Diagnostics Leader’s 2025 Breakout 🚀

IDEXX Laboratories (IDXX): Inside the Pet Diagnostics Leader’s 2025 Breakout 🚀

Company Overview & Business Segments IDEXX Laboratories facility in Markham, Canada (one of the company’s global offices). IDEXX Laboratories, Inc. is a veterinary diagnostics and life sciences company that develops, manufactures, and sells products and services for animal health and water testing in over 175 countries Pestel Analysis Pestel Analysis. Founded in 1983 and headquartered in Maine, IDEXX has grown into the dominant player in pet healthcare diagnostics, as well as a significant provider in livestock/poultry and water microbiology testing. The company operates through three main business segments Wikipedia: Across these segments, IDEXX’s business model is built on selling durable
3 November 2025
·
Chipotle Stock’s Worst Slump Since 2012 – Bulls and Bears Clash on CMG’s Future

Chipotle Stock’s Worst Slump Since 2012 – Bulls and Bears Clash on CMG’s Future

Current Stock Price and Recent Performance A Chipotle Mexican Grill storefront. The burrito chain’s shares suffered a sharp sell-off in late October 2025. Chipotle’s stock has been reeling in the wake of its Q3 report. After closing at $39.76 just before earnings, CMG plummeted to the low-$30s – a collapse of nearly 20% in one session. The Oct. 30 drop was one of the worst in the company’s history, sending the stock to its lowest level in over two years. By the week’s end (Oct. 31), shares stabilized around $31.69, down about 23% for the week and almost 47% year-to-date.
2 November 2025
···
Rani Therapeutics (RANI) Stock Skyrockets ~200% on $1B Pharma Deal – Will the Rally Last?

Rani Therapeutics Stock Explodes on Obesity-Drug Breakthrough – Analysts Eye $10+ Targets

Stock Performance and Recent Movement Rani shares have exploded in the last month. On Oct 1, 2025 RANI traded around $0.50. A landmark collaboration announced Oct 17 with Japan’s Chugai (up to $1.085B deal) and a simultaneous $60M financing sent the stock soaring. Intraday Oct 17 it jumped from $0.47 to $2.39 (+248%)ts2.tech. By Oct 31 the stock closed at $2.20, a 51.7% gain on that day alonets2.tech. This means RANI is up roughly +20% in the past week (from ~$1.82 on Oct 24 to $2.20) and about +330% in Octoberinvesting.cominvesting.com.This rally propelled RANI well above Nasdaq’s $1 minimum bid
1 November 2025
··
AI Goldmine or Next Bubble? Inside Credo (CRDO) Stock’s 1300% Surge and Future Outlook

AI Goldmine or Next Bubble? Inside Credo (CRDO) Stock’s 1300% Surge and Future Outlook

Latest Stock Price and Momentum Credo (NASDAQ: CRDO) has been on a tear in late 2025, with its stock price around $188 as of October 31, 2025. This represents a ~12% jump in one day and extends a powerful rally that saw shares touch new highs. Just yesterday the stock hit $179.13 intraday, a 52-week peak. Notably, Credo’s stock closed 2024 near the $60–$70 range; it has since nearly tripled in 2025 amid feverish interest in AI-related tech companies. Year-to-date, CRDO is up roughly +180%, and over the past 12 months it has climbed about +350% – an exceptional run
31 October 2025
·····
Arbor Realty Trust’s 12% Dividend: Golden Opportunity or Yield Trap in 2025?

Arbor Realty Trust’s 12% Dividend: Golden Opportunity or Yield Trap in 2025?

1. Company Overview Arbor Realty Trust, Inc. is a specialized real estate finance company operating as an externally-managed REIT. Founded in 2003 and headquartered in Uniondale, NY, Arbor’s business is centered on originating, investing in, and servicing real estate loans – primarily in the multifamily housing sector (apartment complexes and single-family rental portfolios) as well as various commercial real estate assetsstocktitan.net. The company’s integrated platform provides bridge loans, mezzanine financing, preferred equity, and other structured finance products on its balance sheet, while also acting as a major agency loan originator selling to government-sponsored entities. Arbor’s dual business segments are: Business
31 October 2025
···
EPWK Holdings (EPWK): From $26 High-Flyer to Penny Stock – Can This Creative Marketplace Rebound?

EPWK Holdings (EPWK): From $26 High-Flyer to Penny Stock – Can This Creative Marketplace Rebound?

EPWK Holdings Ltd. is a China-based provider of online creative services, operating a cloud-sourcing platform that connects businesses (buyers) with freelance talent (sellers) across design, development, marketing, and related fields Investing Reuters. Often described as a “creative services marketplace,” EPWK matches millions of small businesses with skilled providers for tasks like graphic design, web development, and copywriting. The company was incorporated in the Cayman Islands in 2022 and conducts its operations in China through subsidiaries and a VIE structure Investing. Stock Snapshot (NASDAQ: EPWK): As of Oct 31, 2025, EPWK’s stock traded around $0.13–$0.14 per share, after a startling one-day
31 October 2025
···
Chevron (CVX) Stock Rallies on $2B Pipeline Deal – Could $200 Be Next?

Chevron’s Next Big Move: CVX Stock Could Skyrocket on $55B Hess Deal & Low-Carbon Push

In summary, as of Oct 31, 2025 Chevron stands as a dividend-rich, integrated energy leader navigating a weak-oil cycle. Its stock is trading near multi-month lows but backed by record production and cash flow. Short-term catalysts include the Hess synergies and any rebound in oil prices. Longer-term, Chevron emphasizes high-return oil projects (Guyana, Permian) and steady shareholder returns, while gradually investing in lower-carbon ventures. Key factors to watch are global oil demand trends (especially in Asia), OPEC supply decisions, and the results of Q4 earnings (including Exxon, Shell). Analyst consensus sees moderate upside if oil stabilizes, but Chevron – “one of
31 October 2025
····
Nvidia’s Meteoric October: $4 Trillion Milestone, Mega AI Deals, and Unstoppable Momentum

Nvidia Stock Skyrockets Amid AI Frenzy – Is $300 Next?

Nvidia’s Performance & Valuation Nvidia’s stock has been on a tear in October 2025, fueled by the relentless AI boom. It briefly became the world’s most valuable company (~$4.4–$4.5T) in early Octoberts2.tech. By month-end it hit a record high around $195 per share, before a modest pullback into the low-$180s on profit-takingts2.tech. As of Oct 31, NVDA trades near $202.89reuters.com, well above its closing price of ~$184 on Oct 28. Year-to-date, the stock is up about +30%, far outstripping the S&P 500’s gain. This surge reflects “unrelenting AI spending” driving Nvidia’s revenue and cash flow prospectsreuters.comts2.tech. Veteran analyst Matt Britzman
31 October 2025
···
1 … 63 64 65 66 67 … 69

Stock Market Today

Rio Tinto stock jumps as Glencore mega-merger is shelved; what to watch next week

Rio Tinto stock jumps as Glencore mega-merger is shelved; what to watch next week

7 February 2026
Rio Tinto’s U.S. shares closed up 2.5% at $93.37 Friday after the company ruled out a merger with Glencore, triggering a six-month “no-bid” lockout under UK takeover rules. Both companies cited disagreements over valuation. Attention now turns to Rio’s Feb. 19 results and iron ore prices, which fell below $100 a tonne amid weak Chinese demand.
iFAST share price drops 3% as markets shut; earnings next week in focus

iFAST share price drops 3% as markets shut; earnings next week in focus

7 February 2026
iFAST shares fell 3.2% to S$9.64 in heavy trading Friday, closing near the day’s low as investors awaited FY2025 results due Feb. 12. The stock is about 13% below its 52-week high. iFAST recently agreed to buy a 30% stake in Financial Alliance for S$19.6 million, pending regulatory approval. Assets under administration stood at S$30.62 billion as of Sept. 30.
Sembcorp Industries share price: what to watch after Friday dip as Feb 25 results near

Sembcorp Industries share price: what to watch after Friday dip as Feb 25 results near

7 February 2026
Sembcorp shares closed at S$6.05 on Friday, down 0.33%, as Singapore’s STI dropped 0.8%. Shareholders approved the A$6.5 billion Alinta Energy takeover on Jan 30, but the deal still faces regulatory and closing conditions. Sembcorp will release FY2025 results on Feb 25 before market open. Trading volume reached about 4.3 million shares.
Go toTop